CellaVision AB (publ) (CLVSF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for CellaVision AB (publ) (CLVSF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $13.49

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $321,757,376

Daily Volume: 0

Performance Metrics

1 Week: -16.39%

1 Month: -16.39%

3 Months: -22.02%

6 Months: -30.03%

1 Year: -30.03%

YTD: -20.65%

About CellaVision AB (publ) (CLVSF)

Dive into the latest financial snapshot of CellaVision AB (publ) (CLVSF). With a current trading price of 13.49, the stock has experienced a daily shift of $0.00 / 0.00%. The company's market capitalization stands impressively at 321,757,376. Track its year-to-date performance, which is at -20.65%, alongside its weekly, monthly, and yearly trends.

Company Details

Employees: 251

Sector: Health technology

Industry: Medical specialties

Country: Sweden

Details

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.

Selected stocks

Select Harvests Ltd. (SHVTF)

GPT Group (GPTGF)

DETERRA ROYALTIES LTD. (DETRF)